Α-synuclein misfolding and Parkinson's disease
- PMID: 22024360
- DOI: 10.1016/j.bbadis.2011.10.002
Α-synuclein misfolding and Parkinson's disease
Abstract
Substantial evidence links α-synuclein, a small highly conserved presynaptic protein with unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has been identified as the major component of Lewy bodies and Lewy neurites, the characteristic proteinaceous deposits that are the hallmarks of PD. α-Synuclein is a typical intrinsically disordered protein, but can adopt a number of different conformational states depending on conditions and cofactors. These include the helical membrane-bound form, a partially-folded state that is a key intermediate in aggregation and fibrillation, various oligomeric species, and fibrillar and amorphous aggregates. The molecular basis of PD appears to be tightly coupled to the aggregation of α-synuclein and the factors that affect its conformation. This review examines the different aggregation states of α-synuclein, the molecular mechanism of its aggregation, and the influence of environmental and genetic factors on this process.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Curr Protein Pept Sci. 2009 Oct;10(5):483-99. doi: 10.2174/138920309789351921. Curr Protein Pept Sci. 2009. PMID: 19538146 Free PMC article. Review.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
-
α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):890-908. doi: 10.1016/j.bbapap.2019.03.001. Epub 2019 Mar 7. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30853581 Review.
-
Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.Int J Biol Macromol. 2013 Sep;60:196-205. doi: 10.1016/j.ijbiomac.2013.05.032. Epub 2013 Jun 5. Int J Biol Macromol. 2013. PMID: 23748003 Review.
-
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.FEBS Lett. 2012 Sep 21;586(19):3222-8. doi: 10.1016/j.febslet.2012.06.040. Epub 2012 Jul 4. FEBS Lett. 2012. PMID: 22771474
Cited by
-
Species-barrier on the cross-species oral transmission of bovine AA amyloidosis in mice.J Vet Med Sci. 2021 Jul 10;83(6):962-967. doi: 10.1292/jvms.20-0713. Epub 2021 Apr 28. J Vet Med Sci. 2021. PMID: 33907055 Free PMC article.
-
Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease.Yale J Biol Med. 2016 Jun 27;89(2):215-25. eCollection 2016 Jun. Yale J Biol Med. 2016. PMID: 27354847 Free PMC article. Review.
-
Characterization of Protein Structural Changes in Living Cells Using Time-Lapsed FTIR Imaging.Anal Chem. 2015 Jun 16;87(12):6025-31. doi: 10.1021/acs.analchem.5b00371. Epub 2015 May 28. Anal Chem. 2015. PMID: 25965274 Free PMC article.
-
How important is the N-terminal acetylation of alpha-synuclein for its function and aggregation into amyloids?Front Neurosci. 2022 Nov 16;16:1003997. doi: 10.3389/fnins.2022.1003997. eCollection 2022. Front Neurosci. 2022. PMID: 36466161 Free PMC article. Review.
-
The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication.Sci Rep. 2016 Apr 15;6:24475. doi: 10.1038/srep24475. Sci Rep. 2016. PMID: 27080380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical